MENU
XLO
AS OF
Nov 28, 11:14 AM (EDT)
Price
$0.75
Change
-$0.00 (-0.00%)
Capitalization
39.38M
96 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xilio Therapeutics (XLO) Earnings Date & Reports

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments... Show more

A.I. Advisor
published Earnings

XLO is expected to report earnings to fall 6.91% to -10 cents per share on March 04

Xilio Therapeutics XLO Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Missed
by $0.06
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.37
Q4'24
Beat
by $0.06
The last earnings report on November 13 showed earnings per share of -10 cents, missing the estimate of -5 cents. With 22.09K shares outstanding, the current market capitalization sits at 39.38M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
XLO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XLO showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for XLO
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com